Nilogen Oncosystems
Is this your company? Claim this profile
Analytical & Bioanalytical Services
Contract Research Organization
Company Overview
About
Nilogen Oncosystems is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:United States
Founded:2013
Employees:313
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
Global
Regulatory Approvals
Drug Approval Z65ZZR
Health Canada · #APR-S1A82HC7 · 2020-07-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-X7Y0LCXV
Issued: 2020-06-16
Expires: 2025-08-05
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-KE9UK7V4
Issued: 2020-01-10
Expires: 2025-11-18
Health Canada GMP
Health Canada
Cert #: CERT-0JJ5PE1W
Issued: 2020-09-24
Expires: 2025-11-13
Loading CDMO intelligence...
Key facts about Nilogen Oncosystems
- Nilogen Oncosystems is headquartered in the United States.
- Nilogen Oncosystems was founded in 2013.
- Nilogen Oncosystems has 313 employees.
- Nilogen Oncosystems's capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like Nilogen Oncosystems
Directory pages this company appears in, each with the full list of matching manufacturers.